About this item:

503 Views | 271 Downloads

Author Notes:

Corresponding Author: Sarah T. Hawley, PhD, Professor, Departments of Internal Medicine and Health Management and Policy, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 406E, Ann Arbor, MI 48109-2800, Office: 734-936-4787, sarahawl@med.umich.edu

Lauren Wallner: conceptualization, methodology, investigation, writing original draft, writing review and editing, and visualization

Yun Li: methodology, software, formal analysis, investigation, writing original draft, writing review and editing, and visualization

M. Chandler McLeod: methodology, software, formal analysis, investigation, writing original draft, writing review and editing, and visualization

Ann Hamilton: investigation, resources, writing review and editing, and project administration

Kevin Ward: investigation, resources, writing review and editing, and project administration

Christine Veenstra: writing original draft, writing review and editing, and visualization

Lawrence An: conceptualization, investigation, and writing review and editing

Nancy Janz: conceptualization, methodology, investigation, and writing review and editing

Steven Katz: conceptualization, methodology, investigation, resources, writing original draft, writing review and editing, visualization, supervision, project administration, and funding acquisition

Sarah Hawley: conceptualization, methodology, investigation, writing original draft, writing review and editing, and visualization

We acknowledge the work of our project staff (Mackenzie Crawford, M.P.H. and Kiyana Perrino, M.P.H. from the Georgia Cancer Registry; Jennifer Zelaya, Pamela Lee, Maria Gaeta, Virginia Parker, B.A. and Renee Bickerstaff-Magee from USC; Rebecca Morrison, M.P.H., Alexandra Jeanpierre, M.P.H., Stefanie Goodell, B.S., Paul Abrahamse, M.A., Irina Bondarenko, M.S. and Rose Juhasz, Ph.D. from the University of Michigan).

We acknowledge with gratitude our survey respondents.

Conflicts of interest: None

Subjects:

Research Funding:

This work was funded by grant P01CA163233 to the University of Michigan from the National Cancer Institute and by grant RSG-14-035-01 from the American Cancer Society.

Cancer incidence data collection was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP003862-04/DP003862; the NCI’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California (USC), and contract HHSN261201000034C awarded to the Public Health Institute.

Cancer incidence data collection in Georgia was supported by contract HHSN261201300015I, Task Order HHSN26100006 from the NCI and cooperative agreement 5NU58DP003875-04-00 from the CDC.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • breast cancer
  • breast cancer study
  • caregivers
  • decision-support networks
  • family
  • informal decision support
  • treatment decision making
  • CONTRALATERAL PROPHYLACTIC MASTECTOMY
  • SIGNIFICANT OTHERS
  • FAMILY
  • CARE
  • DETERMINANTS
  • INVOLVEMENT
  • PARTICIPATION
  • PERSPECTIVES
  • EXPERIENCES

Decision-support networks of women newly diagnosed with breast cancer

Tools:

Journal Title:

Cancer

Volume:

Volume 123, Number 20

Publisher:

, Pages 3895-3903

Type of Work:

Article | Post-print: After Peer Review

Abstract:

BACKGROUND: Little is known about the size and characteristics of the decision-support networks of women newly diagnosed with breast cancer and whether their involvement improves breast cancer treatment decisions. METHODS: A population-based sample of patients newly diagnosed with breast cancer in 2014 and 2015, as reported to the Georgia and Los Angeles Surveillance, Epidemiology, and End Results registries, were surveyed approximately 7 months after diagnosis (N = 2502; response rate, 68%). Network size was estimated by asking women to list up to 3 of the most important decision-support persons (DSPs) who helped them with locoregional therapy decisions. Decision deliberation was measured using 4 items assessing the degree to which patients thought through the decision, with higher scores reflecting more deliberative breast cancer treatment decisions. The size of the network (range, 0-3 or more) was compared across patient-level characteristics, and adjusted mean deliberation scores were estimated across levels of network size using multivariable linear regression. RESULTS: Of the 2502 women included in this analysis, 51% reported having 3 or more DSPs, 20% reported 2, 18% reported 1, and 11% reported not having any DSPs. Married/partnered women, those younger than 45 years, and black women all were more likely to report larger network sizes (all P <.001). Larger support networks were associated with more deliberative surgical treatment decisions (P <.001). CONCLUSIONS: Most women engaged multiple DSPs in their treatment decision making, and involving more DSPs was associated with more deliberative treatment decisions. Future initiatives to improve treatment decision making among women with breast cancer should acknowledge and engage informal DSPs. Cancer 2017;123:3895-903. © 2017 American Cancer Society.

Copyright information:

© 2017 American Cancer Society

Export to EndNote